Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

ERA-NET: Sustained collaboration of national and regional programmes in cancer research

Projektbeschreibung

20 Länder gemeinsam im Kampf gegen Krebs

Krebs ist trotz stetiger Fortschritte in Forschung und Therapie weltweit eine große Gesundheitsgefahr und die translationale Krebsforschung bildet den Schlüssel für entsprechende Maßnahmen, Wissen und Prävention. Im EU-finanzierten Projekt TRANSCAN-3 kommen 31 Förderorganisationen aus 20 Ländern zusammen, um gemeinsam an einer einflussreichen translationalen Krebsforschung zu arbeiten. Aufrufe zur Vorschlagseinreichung werden bei TRANSCAN-3 gemeinsam und grenzüberschreitend ausgegeben und die internationale und interregionale Zusammenarbeit wird bestmöglich ausgeschöpft, um einflussreiche Beiträge zu liefern, aber auch ein nachhaltiges Modell für die Finanzierung bahnbrechender translationaler Krebsforschung innerhalb und außerhalb Europas zu bieten.

Ziel

Cancer is a worldwide health burden and a major public health challenge. Despite significant advances in the understanding, prevention, diagnostics and treatment, cancer remains a public health problem in Europe and the world. In such a setting, translational cancer research plays a key role in successfully addressing the growing burden of cancer.

The great potential of translational cancer research in Europe will only be achieved when the main barriers are systematically addressed through concerted actions between public and private organisations that provide funds for research, researchers, healthcare providers and all those engaged in the cancer research spectrum. Moreover, adequate and systematic financial support backed by a strong political commitment is absolutely essential to help reduce the burden of cancer that European citizens are currently facing.

In this context, the TRANSCAN-3 network, with a strong background in funding cancer research, embodies an excellent model of cross-national cooperation by bringing together 31 funding organisations, from 20 countries, with the common goal of supporting high-impact translational cancer research through cross-national joint calls for proposals, and by an efficient investment of dedicated national/regional public funding, leveraged with foundation/charity-based resources and EU financial support.

Building up on the well-established cooperation and accomplishments, through the harmonisation of national/regional funding mechanisms and programmes, plus continued and sustained series of efforts for the access to and sharing of data on cancer research, this TRANSCAN-3 project also aims at becoming a catalysts for a sustainable model of funding of high-impact cancer research in Europe and beyond, with an approach to effectively engage relevant stakeholders (patients, society as a whole, policy makers, etc.) in different stages of the action.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

ERA-NET-Cofund - ERA-NET Cofund

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) H2020-SC1-BHC-2018-2020

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

MINISTERO DELLA SALUTE
Netto-EU-Beitrag
€ 1 783 692,90
Adresse
Via Giorgio Ribotta 5
00144 Roma
Italien
Region
Centro (IT) Lazio Roma
Aktivitätstyp
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Links
Gesamtkosten
€ 5 405 130,00

Beteiligte (32)